Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alice Giotta Lucifero & Sabino Luzzi. (2022) Emerging immune-based technologies for high-grade gliomas. Expert Review of Anticancer Therapy 22:9, pages 957-980.
Read now
Read now
Burcu Devrim, Zeynep Busra Bolat, Dilek Telci, Fikrettin Şahin, Sevgi Gulyuz, Umut Ugur Ozkose, Ozgur Yilmaz & Asuman Bozkır. (2021) Design and evaluation of peptide-18-targeted nanoliposomes constructed by poly(2-oxazoline)-DOPE for doxorubicin delivery. Journal of Microencapsulation 38:5, pages 285-297.
Read now
Read now
Vaishali Y. Londhe & Varada Date. (2020) Personalized neoantigen vaccines: a glimmer of hope for glioblastoma. Expert Review of Vaccines 19:5, pages 407-417.
Read now
Read now
Erika Vacchelli, Isabelle Martins, Alexander Eggermont, Wolf Hervé Fridman, Jerome Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2012) Trial watch. OncoImmunology 1:9, pages 1557-1576.
Read now
Read now
Articles from other publishers (46)
Kelly M Hotchkiss, Kristen A Batich, Aditya Mohan, Rifaquat Rahman, Steven Piantadosi & Mustafa Khasraw. (2023) Dendritic cell vaccine trials in gliomas: Untangling the lines. Neuro-Oncology.
Crossref
Crossref
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, Marzieh Ghollasi, Nikoo fathi, Shamin Rezaei, Elahe Sadat Hejazi, Amirabbas Kakavand, Hamidreza Saebfar, Mehrdad Hashemi, Mohammad Ali Sheikh Beig Goharrizi, Shokooh Salimimoghadam, Mohsen Rashidi, Afshin Taheriazam & Saeed Samarghandian. (2022) STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response. Pharmacological Research 182, pages 106311.
Crossref
Crossref
Gabriela Green-Tripp, Callum Nattress & Gunnel Halldén. (2022) Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Sylwia Pabian‐Jewuła, Aneta Bragiel‐Pieczonka & Marcin Rylski. (2022) Ying Yang 1 engagement in brain pathology. Journal of Neurochemistry 161:3, pages 236-253.
Crossref
Crossref
G. P. Guens, V. D. Sanikovich, V. A. Mileyko & A. A. Lebedeva. (2021) Glioblastoma: a molecular genetic portrait and modern therapeutic strategies for drug treatment. Advances in Molecular Oncology 8:3, pages 60-76.
Crossref
Crossref
Alice Giotta Lucifero & Sabino Luzzi. (2021) Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II). Brain Sciences 11:8, pages 976.
Crossref
Crossref
Mario Fidanza, Puja GuptaAnin Sayana, Varun Shanker, Svenja-Maria Pahlke, Brandon VuFanny KrantzAruna AzameeraNicollette WongNavya AnneYuanxuan XiaJiming Rong, Avani AnneStephen SkirbollMichael Lim & Albert J. Wong. (2021) Enhancing proteasomal processing improves survival for a peptide vaccine used to treat glioblastoma. Science Translational Medicine 13:598.
Crossref
Crossref
Alice Giotta Lucifero & Sabino Luzzi. (2021) Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I). Brain Sciences 11:3, pages 386.
Crossref
Crossref
Kelly M. Hotchkiss & John H. Sampson. (2020) Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor. Journal of Neuro-Oncology 151:1, pages 55-62.
Crossref
Crossref
壮 李. (2020) Current Status of Glioblastoma Treatment. Advances in Clinical Medicine 10:12, pages 2875-2882.
Crossref
Crossref
Liquan Wu, Fang Wang, Jiang Xu & Zhibiao Chen. (2019) PTPN2 induced by inflammatory response and oxidative stress contributed to glioma progression. Journal of Cellular Biochemistry 120:11, pages 19044-19051.
Crossref
Crossref
Wei Li, Lin Wang, Xiang-Bo Ji, Li-Hong Wang, Xin Ge, Wei-Tao Liu, Ling Chen, Zhong Zheng, Zhu-Mei Shi, Ling-Zhi Liu, Marie C. Lin, Jie-Yu Chen & Bing-Hua Jiang. (2019) MiR-199a Inhibits Tumor Growth and Attenuates Chemoresistance by Targeting K-RAS via AKT and ERK Signalings. Frontiers in Oncology 9.
Crossref
Crossref
Yingxuan Zhang, Zheyan Fang, Ruizhen Li, Xiaotian Huang & Qiong Liu. (2019) Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy. Cancers 11:9, pages 1314.
Crossref
Crossref
Alberto Grandi, Laura Fantappiè, Carmela Irene, Silvia Valensin, Michele Tomasi, Simone Stupia, Riccardo Corbellari, Elena Caproni, Ilaria Zanella, Samine J. Isaac, Luisa Ganfini, Luca Frattini, Enrico König, Assunta Gagliardi, Simona Tavarini, Chiara Sammicheli, Matteo Parri & Guido Grandi. (2018) Vaccination With a FAT1-Derived B Cell Epitope Combined With Tumor-Specific B and T Cell Epitopes Elicits Additive Protection in Cancer Mouse Models. Frontiers in Oncology 8.
Crossref
Crossref
Kewal K. Jain. (2018) A Critical Overview of Targeted Therapies for Glioblastoma. Frontiers in Oncology 8.
Crossref
Crossref
Shen Jing, Yujia He, Yanqiong He, Liang Wang, Jianhua Jia, Xiaomin Shan, Shuang Liu, Min Tang, Zhiping Peng & Xujie Liu. (2018) Imaging Potential Evaluation of Fab Derived from the Anti-EGFRvIII Monoclonal Antibody 4G1. Radiation Research 190:2, pages 194-203.
Crossref
Crossref
Lili Sun, Shuye Yu, Hui Xu, Yanwen Zheng, Juntang Lin, Meiyan Wu, Jide Wang, Aidong Wang, Qing Lan, Frank Furnari, Webster Cavenee, Benjamin Purow & Ming Li. (2018) FHL2 interacts with EGFR to promote glioblastoma growth. Oncogene 37:10, pages 1386-1398.
Crossref
Crossref
Dehua Li, Wei Shan, Yan Fang, Pan Wang & Jicheng Li. (2017) miR-137 acts as a tumor suppressor via inhibiting CXCL12 in human glioblastoma. Oncotarget 8:60, pages 101262-101270.
Crossref
Crossref
Alberto Grandi, Michele Tomasi, Ilaria Zanella, Luisa Ganfini, Elena Caproni, Laura Fantappiè, Carmela Irene, Luca Frattini, Samine J. Isaac, Enrico König, Francesca Zerbini, Simona Tavarini, Chiara Sammicheli, Fabiola Giusti, Ilaria Ferlenghi, Matteo Parri & Guido Grandi. (2017) Synergistic Protective Activity of Tumor-Specific Epitopes Engineered in Bacterial Outer Membrane Vesicles. Frontiers in Oncology 7.
Crossref
Crossref
Laura Fantappiè, Carmela Irene, Micaela De Santis, Alessandro Armini, Assunta Gagliardi, Michele Tomasi, Matteo Parri, Valeria Cafardi, Serena Bonomi, Luisa Ganfini, Francesca Zerbini, Ilaria Zanella, Chiara Carnemolla, Luca Bini, Alberto Grandi & Guido Grandi. (2017) Some Gram-negative Lipoproteins Keep Their Surface Topology When Transplanted from One Species to Another and Deliver Foreign Polypeptides to the Bacterial Surface. Molecular & Cellular Proteomics 16:7, pages 1348-1364.
Crossref
Crossref
Dong Jin, Xin Yu, Bing Chen, Zhitao Li, Jia Ding, Xiuyun Zhao & Gaofu Qi. (2017) Combined immunotherapy of breast cancer with EGF and VEGF vaccines from DNA shuffling in a mouse model. Immunotherapy 9:7, pages 537-553.
Crossref
Crossref
Eiichi ISHIKAWA, Tetsuya YAMAMOTO & Akira MATSUMURA. (2017) Prospect of Immunotherapy for Glioblastoma: Tumor Vaccine, Immune Checkpoint Inhibitors and Combination Therapy. Neurologia medico-chirurgica 57:7, pages 321-330.
Crossref
Crossref
Xiaokun Shen, Jie Li, Wenfeng Liao, Jiwen Wang, Huanjun Chen, Yanli Yao, Houbao Liu & Kan Ding. (2016) microRNA-149 targets caspase-2 in glioma progression. Oncotarget 7:18, pages 26388-26399.
Crossref
Crossref
Qing Lan, Aidong Wang, Yanwei Cheng, Akitaki Mukasa, Jiawei Ma, Lei Hong, Shuye Yu, Lili Sun, Qiang Huang, Benjamin Purow & Ming Li. (2016)
Guanylate binding protein-1 mediates EGFRvIII and promotes glioblastoma growth
in vivo
but not
in vitro
. Oncotarget 7:9, pages 9680-9691.
Crossref
Crossref
Stephanie Combs, Thomas Schmid, Peter Vaupel & Gabriele Multhoff. (2016) Stress Response Leading to Resistance in Glioblastoma—The Need for Innovative Radiotherapy (iRT) Concepts. Cancers 8:1, pages 15.
Crossref
Crossref
Martha R. Neagu & David A. Reardon. (2015) An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors. Current Treatment Options in Oncology 16:11.
Crossref
Crossref
Constantinos Alifieris & Dimitrios T. Trafalis. (2015) Glioblastoma multiforme: Pathogenesis and treatment. Pharmacology & Therapeutics 152, pages 63-82.
Crossref
Crossref
Kevin J. Hamblett, Carl J. Kozlosky, Sophia Siu, Wesley S. Chang, Hua Liu, Ian N. Foltz, Esther S. Trueblood, David Meininger, Taruna Arora, Brian Twomey, Steven L. Vonderfecht, Qing Chen, John S. Hill & William C. Fanslow. (2015) AMG 595, an Anti-EGFRvIII Antibody–Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing Glioblastoma. Molecular Cancer Therapeutics 14:7, pages 1614-1624.
Crossref
Crossref
Justin D. Lathia, Stephen C. Mack, Erin E. Mulkearns-Hubert, Claudia L.L. Valentim & Jeremy N. Rich. (2015) Cancer stem cells in glioblastoma. Genes & Development 29:12, pages 1203-1217.
Crossref
Crossref
A. Gupta, R. J. Young, A. D. Shah, A. D. Schweitzer, J. J. Graber, W. Shi, Z. Zhang, J. Huse & A. M. P. Omuro. (2014) Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification. Clinical Neuroradiology 25:2, pages 143-150.
Crossref
Crossref
Jiannan Zhang, Tao Chen, Qin Mao, Jinbo Lin, Jun Jia, Shanquan Li, Wenhao Xiong, Yingying Lin, Zhiqiang Liu, Xiaoyu Liu, Hailiang Zhao, Guisong Wang, Duo Zheng, Shuqi Qiu & Jianwei Ge. (2014)
PDGFR‐β‐activated
ACK
1‐
AKT
Signaling Promotes Glioma Tumorigenesis
. International Journal of Cancer 136:8, pages 1769-1780.
Crossref
Crossref
Taemin Oh, Eli T. Sayegh, Shayan Fakurnejad, Daniel Oyon, Jonathan Balquiedra Lamano, Joseph David DiDomenico, Orin Bloch & Andrew T. Parsa. (2014) Vaccine Therapies in Malignant Glioma. Current Neurology and Neuroscience Reports 15:1.
Crossref
Crossref
Erica C Kaye, Justin N Baker & Alberto Broniscer. (2014) Management of diffuse intrinsic pontine glioma in children: current and future strategies for improving prognosis. CNS Oncology 3:6, pages 421-431.
Crossref
Crossref
D. A. Reardon, G. Freeman, C. Wu, E. A. Chiocca, K. W. Wucherpfennig, P. Y. Wen, E. F. Fritsch, W. T. Curry, J. H. Sampson & G. Dranoff. (2014) Immunotherapy advances for glioblastoma. Neuro-Oncology 16:11, pages 1441-1458.
Crossref
Crossref
Xiang Yi, Devika S. Manickam, Anna Brynskikh & Alexander V. Kabanov. (2014) Agile delivery of protein therapeutics to CNS. Journal of Controlled Release 190, pages 637-663.
Crossref
Crossref
Mitsutoshi Nakada, Daisuke Kita, Takuya Watanabe, Yutaka Hayashi & Jun-ichiro Hamada. (2014) The mechanism of chemoresistance against tyrosine kinase inhibitors in malignant glioma. Brain Tumor Pathology 31:3, pages 198-207.
Crossref
Crossref
Fenghua Zeng & Raymond C. Harris. (2014) Epidermal growth factor, from gene organization to bedside. Seminars in Cell & Developmental Biology 28, pages 2-11.
Crossref
Crossref
J L Munoz, V Rodriguez-Cruz, S J Greco, S H Ramkissoon, K L Ligon & P Rameshwar. (2014) Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43. Cell Death & Disease 5:3, pages e1145-e1145.
Crossref
Crossref
Mitsutoshi Nakada, Daisuke Kita, Takuya Furuta, Takuya Watanabe, Yutaka Hayashi & Jun-Ichiro Hamada. 2014. Glioma Cell Biology. Glioma Cell Biology
47
75
.
Marc A. Antonyak & Richard A. Cerione. 2014. Cancer Cell Signaling. Cancer Cell Signaling
147
173
.
Chan-Juan Shen, Yu-Xiu Yang, Ethan Q Han, Na Cao, Yun-Fei Wang, Yi Wang, Ying-Ying Zhao, Li-Ming Zhao, Jian Cui, Puja Gupta, Albert J Wong & Shuang-Yin Han. (2013) Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma. Journal of Hematology & Oncology 6:1.
Crossref
Crossref
Gerald C. WallaceIVIV, Yaenette N. Dixon-Mah, W. Alex VandergriftIIIIII, Swapan K. Ray, Catherine P. Haar, Amber M. Mittendorf, Sunil J. Patel, Naren L. Banik, Pierre Giglio & Arabinda Das. (2013) Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma. Metabolic Brain Disease 28:3, pages 355-366.
Crossref
Crossref
Maya Zigler, Alexei Shir & Alexander Levitzki. (2013) Targeted cancer immunotherapy. Current Opinion in Pharmacology 13:4, pages 504-510.
Crossref
Crossref
Markus J. Riemenschneider, David N. Louis, Michael Weller & Peter Hau. (2013) Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach. Acta Neuropathologica 126:1, pages 21-37.
Crossref
Crossref
Anu Stella Mathews, Sahar Ahmed, Mostafa Shahin, Afsaneh Lavasanifar & Kamaljit Kaur. (2013) Peptide Modified Polymeric Micelles Specific for Breast Cancer Cells. Bioconjugate Chemistry 24:4, pages 560-570.
Crossref
Crossref
Christopher Jackson, Jacob Ruzevick, Henry Brem & Michael Lim. (2013) Vaccine strategies for glioblastoma: progress and future directions. Immunotherapy 5:2, pages 155-167.
Crossref
Crossref